Jennifer Zachary

Insider Reports History

Entity
Individual
Location
2000 Galloping Hill Road, Kenilworth, NJ
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Zachary:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Merck & Co., Inc. EVP, General Counsel Common Stock 29.2K $3.67M $125.50 Apr 30, 2024 Direct
REGENXBIO Inc. Director Common Stock 14.3K $226K $15.81 May 31, 2024 Direct
Merck & Co., Inc. EVP, General Counsel Stock Option (Right to Buy) 35.2K Apr 30, 2024 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 24.5K May 31, 2024 Direct

Insider Reports Filed by Jennifer Zachary

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGNX REGENXBIO Inc. May 31, 2024 2 $0 4 Jun 4, 2024 Director
MRK Merck & Co., Inc. Apr 30, 2024 1 $0 4 May 2, 2024 EVP, General Counsel
MRK Merck & Co., Inc. Feb 2, 2024 3 -$4.59M 4 Feb 2, 2024 EVP, General Counsel
MRK Merck & Co., Inc. Jan 22, 2024 1 $2.78M 4 Jan 24, 2024 EVP, General Counsel
RGNX REGENXBIO Inc. Jun 2, 2023 2 $0 4 Jun 6, 2023 Director
MRK Merck & Co., Inc. May 4, 2023 1 -$2.25M 4 May 5, 2023 EVP, General Counsel
MRK Merck & Co., Inc. May 2, 2023 1 $0 4 May 4, 2023 EVP, General Counsel
MRK Merck & Co., Inc. Feb 3, 2023 3 -$3.56M 4 Feb 6, 2023 EVP, General Counsel
MRK Merck & Co., Inc. Jan 23, 2023 1 $1.72M 4 Jan 25, 2023 EVP, General Counsel
MRK Merck & Co., Inc. Oct 28, 2022 8 -$16.4M 4 Nov 1, 2022 EVP, General Counsel
RGNX REGENXBIO Inc. Jun 3, 2022 2 $0 4 Jun 7, 2022 Director
RGNX REGENXBIO Inc. Jun 3, 2022 0 $0 3 Jun 7, 2022 Director
MRK Merck & Co., Inc. May 3, 2022 1 $0 4 May 5, 2022 EVP, General Counsel
MRK Merck & Co., Inc. Feb 24, 2022 1 $1.35M 4 Feb 28, 2022 EVP, General Counsel